Future research should also further validate the diagnostic efficacy of FC across different ethnic populations, clarify its relationship with colorectal tumors staging and localization, and explore its association with tumor molecular characteristics (such as KRAS mutations, BRAF mutations). This evidence concerns the gene KRAS and neoplasm.